Sleep Apnea Oral Appliances Market is Expected to Reach $0.9 Billion | MarketsandMarkets.
January 11, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Sleep Apnea Oral Appliances market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $0.9 billion by 2028, growing...
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
January 08, 2024 08:00 ET
|
ProSomnus Sleep Technologies, Inc.
PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...
Apnimed Announces First Patient Dosed in SynAIRgy, the Second Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
December 21, 2023 08:30 ET
|
Apnimed, Inc.
-- SynAIRgy Compares AD109 to Placebo Over 6 Months in People with OSA who Are Intolerant of or Refuse Positive Airway Pressure (PAP) Therapy, the Current Standard of Care -- Part of a two-study...
Americas Sleep Apnea Market Worth $4.10 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 10, 2023 05:46 ET
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Sleep apnea is a potentially serious sleep disorder where breathing repeatedly stops and starts. Such a condition prevents the patient's body from...
Global Sleep Apnea Market Analysis & Forecast to 2023-2033
November 08, 2023 04:08 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Global Sleep Apnea Market Analysis & Forecast to 2023-2033: Market By Product; By End-user; and by Region" report has been added to ...
Apnimed to Participate in Upcoming November Investor Conferences
November 06, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...
Global Sleep Apnea Implants Market 2023-2027: Increasing Prevalence of Sleep Apnea and Respiratory Disorders Drives Growth
November 03, 2023 06:08 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Sleep Apnea Implants Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The sleep apnea implants market is forecasted...
Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disorders
October 31, 2023 20:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...
Apnimed to Present Review of Recent Data on Investigational Pharmacologic Treatment for Obstructive Sleep Apnea at World Sleep 2023
October 18, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea...
Apnimed to Participate in Upcoming October Investor Conferences
October 11, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...